Citius Oncology
CTOR
16 hedge funds and large institutions have $17M invested in Citius Oncology in 2025 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.
1,614% more capital invested
Capital invested by funds: $990K → $17M (+$16M)
900% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 1
129% more funds holding
Funds holding: 7 → 16 (+9)
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
10.35% more ownership
Funds ownership: 0.32% → 10.66% (+10%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$16.6M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$390K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$275K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$238K |
| 5 |
Renaissance Technologies
New York
|
+$121K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$465K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$33.3K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$18K |
CTOR Hedge Fund Activity: Q3 2025 in Review
16 of the 7,640 institutional investors tracked by Wall St. Rank reported a position in Citius Oncology (CTOR) for Q3 2025, worth a combined $17M — up 1,614% from $990K a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new CTOR positions and 1 closed out — a net gain of 9 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $16.6M. The largest seller was Jane Street, exiting entirely with an estimated $465K sold.
- 16 institutional investors held Citius Oncology (CTOR) as of Q3 2025, up from 7 in Q2 2025.
- Funds reported $17M of Citius Oncology stock for Q3 2025, up 1,614% quarter-over-quarter.
- 10 funds opened new Citius Oncology positions in Q3 2025 and 1 closed out, a net change of +9 holders.
- The largest Citius Oncology buyer in Q3 2025 was Armistice Capital, an estimated $16.6M added.
- The largest Citius Oncology seller in Q3 2025 was Jane Street, an estimated $465K sold.
Based on aggregated 13F filings for Q3 2025.